1061705

Shire Human Genetic Therapies, Inc. — FEI 3009340644

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 25, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lexington, MA (United States)

Additional Details

Sponsor, Contract Research Organization